{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:49:52Z","timestamp":1795114192242,"version":"4.10.3"},"reference-count":102,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ijantimicag.2024.107083","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T13:08:15Z","timestamp":1704460095000},"page":"107083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["A systematic review of peptide nucleic acids (PNAs) with antibacterial activities: Efficacy, potential and challenges"],"prefix":"10.1016","volume":"63","author":[{"given":"Mohamed","family":"El-Fateh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8389-9917","authenticated-orcid":false,"given":"Anushree","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2024.107083_bib0001","series-title":"No time to wait: securing the future from drug-resistant infections. Report to the Secretary-General of the United Nations","year":"2019"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0002","series-title":"Tackling drug-resistant infections globally: Final report and recommendations","author":"O'Neill","year":"2016"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0003","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cell.2020.02.056","article-title":"The science of antibiotic discovery","volume":"181","author":"Lewis","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0004","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41579-019-0293-3","article-title":"Antibiotic development \u2014 economic, regulatory and societal challenges","volume":"18","author":"\u00c5rdal","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0005","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1038\/s41467-019-11303-9","article-title":"Designing development programs for non-traditional antibacterial agents","volume":"10","author":"Rex","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0006","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12275-019-8635-4","article-title":"Antisense peptide nucleic acids as a potential anti-infective agent","volume":"57","author":"Lee","year":"2019","journal-title":"J Microbiol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0007","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1962210","article-title":"Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide","volume":"254","author":"Nielsen","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0008","series-title":"Peptide nucleic acids: Methods and protocols","article-title":"Peptide nucleic acids methods and protocols second edition preface","author":"Nielsen","year":"2014"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0009","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/0006-2952(94)90171-6","article-title":"Stability of peptide nucleic acids in human serum and cellular extracts","volume":"48","author":"Demidov","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0010","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/365566a0","article-title":"PNA hybridizes to complementary oligonucleotides obeying the Watson\u2013Crick hydrogen-bonding rules","volume":"365","author":"Egholm","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0011","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/sj.ejhg.5201226","article-title":"The peptide nucleic acids (PNAs), powerful tools for molecular genetics and cytogenetics","volume":"12","author":"Pellestor","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0012","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/nar\/gkx1239","article-title":"Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs","volume":"46","author":"Shen","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0013","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cbpa.2019.06.006","article-title":"Peptide nucleic acid (PNA) and its applications in chemical biology, diagnostics, and therapeutics","volume":"52","author":"Saarbach","year":"2019","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0014","doi-asserted-by":"crossref","first-page":"e89082","DOI":"10.1371\/journal.pone.0089082","article-title":"Species-selective killing of bacteria by antimicrobial peptide-PNAs","volume":"9","author":"Mondhe","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s42003-021-01856-1","article-title":"Facile accelerated specific therapeutic (fast) platform develops antisense therapies to counter multidrug-resistant bacteria","volume":"4","author":"Eller","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0016","doi-asserted-by":"crossref","first-page":"30699","DOI":"10.1073\/pnas.1922187117","article-title":"Transcriptome-based design of antisense inhibitors potentiates carbapenem efficacy in CRE Escherichia coli","volume":"117","author":"Aunins","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0017","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0018","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing. CLSI supplement M100: Clinical and Laboratory Standards Institute. 2021. https:\/\/clsi.org\/about\/press-releases\/clsi-publishes-m100-performance-standards-for-antimicrobial-susceptibility-testing-31st-edition\/ [accessed 22 April 2023]."},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0019","unstructured":"EUCAST. Breakpoint tables for interpretation of mics and zone diameters European Committee on Antimicrobial Susceptibility Testing. 2023. https:\/\/www.eucast.org\/clinical_breakpoints [accessed 22 April 2023]."},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103825","article-title":"AdeB efflux pump gene knockdown by mRNA mediated peptide nucleic acid in multidrug resistance Acinetobacter baumannii","volume":"139","author":"Abdi","year":"2020","journal-title":"Microb Pathog"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0021","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1038\/mtna.2016.53","article-title":"Targeting multidrug-resistant Staphylococci with an anti-rpoA peptide nucleic acid conjugated to the HIV-1 TAT cell penetrating peptide","volume":"5","author":"Abushahba","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep20832","article-title":"Impact of different cell penetrating peptides on the efficacy of antisense therapeutics for targeting intracellular pathogens","volume":"6","author":"Abushahba","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0023","doi-asserted-by":"crossref","first-page":"e04110","DOI":"10.1016\/j.heliyon.2020.e04110","article-title":"The development of species-specific antisense peptide nucleic acid method for the treatment and detection of viable salmonella","volume":"6","author":"Adebowale","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0024","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/nat.2013.0426","article-title":"Targeting listeria monocytogenes rpoA and rpoD genes using peptide nucleic acids","volume":"23","author":"Alajlouni","year":"2013","journal-title":"Nucleic Acid Ther"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0025","doi-asserted-by":"crossref","first-page":"e29886","DOI":"10.1371\/journal.pone.0029886","article-title":"Targeting RNA polymerase primary \u03c3 70 as a therapeutic strategy against methicillin-resistant Staphylococcus aureus by antisense peptide nucleic acid","volume":"7","author":"Bai","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0026","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.biomaterials.2011.09.075","article-title":"Antisense inhibition of gene expression and growth in Gram negative bacteria by cell-penetrating peptide conjugates of peptide nucleic acids targeted to rpoD gene","volume":"33","author":"Bai","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0027","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00497-22","article-title":"Antimicrobial activity of peptide-coupled antisense peptide nucleic acids in Streptococcus pneumoniae","volume":"10","author":"Barkowsky","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0028","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.omtn.2019.09.010","article-title":"Influence of different cell-penetrating peptides on the antimicrobial efficiency of PNAs in Streptococcus pyogenes","volume":"18","author":"Barkowsky","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0029","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1016\/j.bmcl.2018.07.037","article-title":"Antimicrobial synergy between mRNA targeted peptide nucleic acid and antibiotics in E. coli","volume":"28","author":"Castillo","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0030","first-page":"e01262-62","article-title":"Potentiating the anti-tuberculosis efficacy of peptide nucleic acids through combinations with permeabilizing drugs","volume":"10","author":"Cotta Karishma","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0031","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/acsinfecdis.5b00042","article-title":"Sequence-specific peptide nucleic acid-based antisense inhibitors of TEM-1 \u03b2-lactamase and mechanism of adaptive resistance","volume":"1","author":"Courtney","year":"2015","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0032","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1089\/154545703322860753","article-title":"The translation start codon region is sensitive to antisense PNA inhibition in Escherichia coli","volume":"13","author":"Dryselius","year":"2003","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0033","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jac\/dki173","article-title":"Antimicrobial synergy between mRNA-and protein-level inhibitors","volume":"56","author":"Dryselius","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0034","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.omtn.2021.06.009","article-title":"Activating the Cpx response induces tolerance to antisense PNA delivered by an arginine-rich peptide in Escherichia coli","volume":"25","author":"Frimodt-M\u00f8ller","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/nat.2012.0370","article-title":"Potent antibacterial antisense peptide\u2013peptide nucleic acid conjugates against Pseudomonas aeruginosa","volume":"22","author":"Ghosal","year":"2012","journal-title":"Nucleic Acid Ther"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0036","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/cb300434e","article-title":"Role of SbmA in the uptake of peptide nucleic acid (PNA)-peptide conjugates in E. coli","volume":"8","author":"Ghosal","year":"2013","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-015-0599-x","article-title":"Oxacillin sensitization of methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus pseudintermedius by antisense peptide nucleic acids in vitro","volume":"15","author":"Goh","year":"2015","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.01032","article-title":"PNA length restriction of antibacterial activity of peptide-PNA conjugates in Escherichia coli through effects of the inner membrane","volume":"10","author":"Goltermann","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.877377","article-title":"Effects of LPS composition in Escherichia coli on antibacterial activity and bacterial uptake of antisense peptide-PNA conjugates","volume":"13","author":"Goltermann","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0040","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/86753","article-title":"Bactericidal antisense effects of peptide\u2013PNA conjugates","volume":"19","author":"Good","year":"2001","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0041","doi-asserted-by":"crossref","first-page":"8369","DOI":"10.1021\/acs.jpcb.6b02081","article-title":"Scanning of 16s ribosomal RNA for peptide nucleic acid targets","volume":"120","author":"G\u00f3rska","year":"2016","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0042","doi-asserted-by":"crossref","first-page":"30613","DOI":"10.1074\/jbc.M603346200","article-title":"Antisense inhibition of RNase P: Mechanistic aspects and application to live bacteria","volume":"281","author":"Gruegelsiepe","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0043","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejmech.2019.02.024","article-title":"Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin-and tigecycline-resistant E. coli and K. pneumoniae","volume":"168","author":"Hansen","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0044","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1021\/acs.bioconjchem.6b00013","article-title":"Antibacterial peptide nucleic acid\u2013antimicrobial peptide (PNA\u2013AMP) conjugates: Antisense targeting of fatty acid biosynthesis","volume":"27","author":"Hansen","year":"2016","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0045","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00253-009-2099-0","article-title":"Sequence-specific bacterial growth inhibition by peptide nucleic acid targeted to the mRNA binding site of 16s rRNA","volume":"84","author":"Hatamoto","year":"2009","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0046","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1021\/acsinfecdis.2c00089","article-title":"Antisense peptide nucleic acid-diaminobutanoic acid dendron conjugates with SbmA-independent antimicrobial activity against Gram negative bacteria","volume":"8","author":"Iubatti","year":"2022","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0047","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/jac\/dkp067","article-title":"Sensitization of Campylobacter jejuni to fluoroquinolone and macrolide antibiotics by antisense inhibition of the CmeABC multidrug efflux transporter","volume":"63","author":"Jeon","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0048","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.biochi.2017.04.001","article-title":"Helix 69 of Escherichia coli 23s ribosomal RNA as a peptide nucleic acid target","volume":"138","author":"Kulik","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0049","first-page":"101","article-title":"Inhibition of mycobacterium smegmatis gene expression and growth using antisense peptide nucleic acids","volume":"9","author":"Kulyt\u00e9","year":"2005","journal-title":"J Mol Microbiol Biotechnol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0050","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1128\/AAC.00709-06","article-title":"Inhibition of gene expression and growth by antisense peptide nucleic acids in a multiresistant \u03b2-lactamase-producing Klebsiella pneumoniae strain","volume":"51","author":"Kurupati","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0051","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.omtn.2019.08.021","article-title":"A novel peptide nucleic acid against the cytidine monophosphate kinase of s. Aureus inhibits staphylococcal infection in vivo","volume":"18","author":"Lee","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2014.09.015","article-title":"Inhibiting the growth of methicillin-resistant Staphylococcus aureus in vitro with antisense peptide nucleic acid conjugates targeting the ftsZ gene","volume":"30","author":"Liang","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0053","doi-asserted-by":"crossref","first-page":"7234","DOI":"10.1016\/j.bmc.2015.10.020","article-title":"Antisense peptide nucleic acid\u2013peptide conjugates for functional analyses of genes in Pseudomonas aeruginosa","volume":"23","author":"Maekawa","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0054","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ijbiomac.2017.02.011","article-title":"An antisense peptide nucleic acid against pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system","volume":"99","author":"Montagner","year":"2017","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0055","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1128\/AAC.00605-13","article-title":"Synergistic effects of anti-CmeA and anti-CmeB peptide nucleic acids on sensitizing Campylobacter jejuni to antibiotics","volume":"57","author":"Mu","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0056","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9040429","article-title":"Targeting of the essential acpP, ftsZ, and rne genes in carbapenem-resistant Acinetobacter baumannii by antisense PNA precision antibacterials","volume":"9","author":"Nejad","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0057","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ymthe.2004.07.006","article-title":"Inhibition of Staphylococcus aureus gene expression and growth using antisense peptide nucleic acids","volume":"10","author":"Nekhotiaeva","year":"2004","journal-title":"Mol Ther"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103646","article-title":"Peptide nucleic acid-mediated re-sensitization of colistin resistance Escherichia coli kp81 harboring mcr-1 plasmid","volume":"135","author":"Nezhadi","year":"2019","journal-title":"Microb Pathog"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0059","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.mt.6300209","article-title":"Antisense PNA accumulates in Escherichia coli and mediates a long post-antibiotic effect","volume":"15","author":"Nikravesh","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0060","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/jac\/dkt381","article-title":"Target optimization for peptide nucleic acid (PNA)-mediated antisense inhibition of the CmeABC multidrug efflux pump in Campylobacter jejuni","volume":"69","author":"Oh","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0061","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s42003-018-0135-2","article-title":"Multiplexed deactivated crispr-cas9 gene expression perturbations deter bacterial adaptation by inducing negative epistasis","volume":"1","author":"Otoupal","year":"2018","journal-title":"Commun Biol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0062","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/s42003-021-02783-x","article-title":"Potentiating antibiotic efficacy via perturbation of non-essential gene expression","volume":"4","author":"Otoupal","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0063","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jac\/dkw384","article-title":"Antimicrobial activity of antisense peptide\u2013peptide nucleic acid conjugates against non-typeable Haemophilus influenzae in planktonic and biofilm forms","volume":"72","author":"Otsuka","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0064","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3389\/fmicb.2017.00687","article-title":"Exploration of using antisense peptide nucleic acid (PNA)-cell penetrating peptide (CPP) as a novel bactericide against fire blight pathogen Erwinia amylovora","volume":"8","author":"Patel","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0065","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1038\/mtna.2013.62","article-title":"Inhibition of growth and gene expression by PNA-peptide conjugates in Streptococcus pyogenes","volume":"2","author":"Patenge","year":"2013","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0066","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.1093\/nar\/gkac362","article-title":"Comprehensive analysis of PNA-based antisense antibiotics targeting various essential genes in uropathogenic Escherichia coli","volume":"50","author":"Popella","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0067","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1093\/nar\/gkab242","article-title":"Global RNA profiles show target selectivity and physiological effects of peptide-delivered antisense antibiotics","volume":"49","author":"Popella","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0068","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijantimicag.2012.11.017","article-title":"Peptide nucleic acids inhibit growth of Brucella suis in pure culture and in infected murine macrophages","volume":"41","author":"Rajasekaran","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0069","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1089\/nat.2016.0644","article-title":"Tetrahedral DNA nanoparticle vector for intracellular delivery of targeted peptide nucleic acid antisense agents to restore antibiotic sensitivity in cefotaxime-resistant Escherichia coli","volume":"27","author":"Readman","year":"2017","journal-title":"Nucleic Acid Ther"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0070","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.02870","article-title":"Artificial activation of Escherichia coli mazEF and hipBA toxin\u2013antitoxin systems by antisense peptide nucleic acids as an antibacterial strategy","volume":"9","author":"R\u00f3wnicki","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0071","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1021\/acsomega.8b03139","article-title":"Inhibition of Escherichia coli growth by vitamin b12\u2013peptide nucleic acid conjugates","volume":"4","author":"R\u00f3wnicki","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.resmic.2021.103837","article-title":"Antisense peptide nucleic acid inhibits the growth of KPC-producing Klebsiella pneumoniae strain","volume":"172","author":"da Silva","year":"2021","journal-title":"Res Microbiol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0073","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.1128\/AAC.01437-12","article-title":"Targeting essential genes in Salmonella enterica Serovar Typhimurium with antisense peptide nucleic acid","volume":"56","author":"Soofi","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0074","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1128\/AAC.49.8.3203-3207.2005","article-title":"Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: Proof of principle using mouse intraperitoneal infection","volume":"49","author":"Tan","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0075","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2217\/fmb-2019-0103","article-title":"Inhibition of growth and gene expression in Staphylococcus aureus by anti-gyra peptide nucleic acid","volume":"14","author":"Tavakoli","year":"2019","journal-title":"Future Microbiol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0076","first-page":"2059","article-title":"Peptide nucleic acid restores colistin susceptibility through modulation of mcr-1 expression in Escherichia coli","volume":"75","author":"Wang","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0077","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1007\/s11033-014-3643-2","article-title":"Inhibition of gene expression and growth of multidrug-resistant Acinetobacter baumannii by antisense peptide nucleic acids","volume":"41","author":"Wang","year":"2014","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0078","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/psc.835","article-title":"Inhibition of bacterial translation and growth by peptide nucleic acids targeted to domain ii of 23s rRNA","volume":"13","author":"Xue-Wen","year":"2007","journal-title":"J Pept Sci"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0079","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1021\/acschembio.0c00822","article-title":"Uptake, stability, and activity of antisense anti-acpP PNA-peptide conjugates in Escherichia coli and the role of SbmA","volume":"16","author":"Yavari","year":"2021","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0080","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27248944","article-title":"Cell-penetrating peptide-peptide nucleic acid conjugates as a tool for protein functional elucidation in the native bacterium","volume":"27","author":"Yokoi","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0081","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-0711-12-22","article-title":"New antibiotics for bad bugs: Where are we?","volume":"12","author":"Bassetti","year":"2013","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0082","series-title":"Antibiotic resistance threats in the united states, 2019","year":"2019"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0083","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0009-9236(03)00018-3","article-title":"Hypothesis: A single clinical trial plus causal evidence of effectiveness is sufficient for drug approval","volume":"73","author":"Peck","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0084","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0085","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41570-021-00313-1","article-title":"Towards the sustainable discovery and development of new antibiotics","volume":"5","author":"Miethke","year":"2021","journal-title":"Nat Rev Chem"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0086","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41579-019-0288-0","article-title":"The global preclinical antibacterial pipeline","volume":"18","author":"Theuretzbacher","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0087","doi-asserted-by":"crossref","first-page":"eabo7793","DOI":"10.1126\/scitranslmed.abo7793","article-title":"The past, present, and future of antibiotics","volume":"14","author":"Cook","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0088","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.2174\/0929867322666150209151209","article-title":"Target based drug design - a reality in virtual sphere","volume":"22","author":"Verma","year":"2015","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0089","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1089\/oli.2007.0088","article-title":"Single acute-dose and repeat-doses toxicity of anti-HIV-1 PNA TAR-penetratin conjugate after intraperitoneal administration to mice","volume":"18","author":"Chaubey","year":"2008","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0090","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/108729002760070803","article-title":"Pharmacokinetics and tissue distribution of a peptide nucleic acid after intravenous administration","volume":"12","author":"McMahon","year":"2002","journal-title":"Antisense Nucleic Acid Drug Dev"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0091","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/acscentsci.3c00016","article-title":"Peptide nucleic acids promise new therapeutics and gene editing tools","volume":"9","author":"Brazil","year":"2023","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0092","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1261\/rna.079263.122","article-title":"Design and off-target prediction for antisense oligomers targeting bacterial mRNAs with the mason web server","volume":"29","author":"Jung","year":"2023","journal-title":"RNA"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0093","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.mib.2011.07.029","article-title":"Is bacterial fatty acid synthesis a valid target for antibacterial drug discovery?","volume":"14","author":"Parsons","year":"2011","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0094","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/nat.2022.0061","article-title":"Considerations in the preclinical assessment of the safety of antisense oligonucleotides","volume":"33","author":"Goyenvalle","year":"2023","journal-title":"Nucleic Acid Ther"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0095","doi-asserted-by":"crossref","unstructured":"Godbey WT. Chapter 4 - genes: The blueprints for proteins editor. In: Godbey WT, editor. Biotechnology and its applications. second edition Academic Press; 2022. p. 73\u2013115. doi:10.1016\/B978-0-12-817726-6.00004-6 [accessed 30 March 2023].","DOI":"10.1016\/B978-0-12-817726-6.00004-6"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0096","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00204-021-03184-z","article-title":"Pharmacology and toxicology of eteplirsen and SRP-5051 for DMD exon 51 skipping: An update","volume":"96","author":"Sheikh","year":"2022","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0097","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1021\/acs.nanolett.8b02166","article-title":"Inhibiting methicillin-resistant Staphylococcus aureus by tetrahedral DNA nanostructure-enabled antisense peptide nucleic acid delivery","volume":"18","author":"Zhang","year":"2018","journal-title":"Nano Lett"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0098","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1246\/bcsj.20210086","article-title":"Recognition of target site in various forms of DNA and RNA by peptide nucleic acid (PNA): From fundamentals to practical applications","volume":"94","author":"Liang","year":"2021","journal-title":"Bull Chem Soc Jpn"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0099","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrmicro1839","article-title":"Membrane lipid homeostasis in bacteria","volume":"6","author":"Zhang","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s43586-022-00118-6","article-title":"A guide to the organ-on-a-chip","volume":"2","author":"Leung","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0101","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1126\/science.aaw7894","article-title":"Organoids-on-a-chip","volume":"364","author":"Park","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2024.107083_bib0102","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/s41591-022-01755-w","article-title":"Intravitreal antisense oligonucleotide sepofarsen in Leber congenital amaurosis type 10: A phase 1b\/2 trial","volume":"28","author":"Russell","year":"2022","journal-title":"Nat Med"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924000013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924000013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:46:04Z","timestamp":1760377564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857924000013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":102,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0924857924000013"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107083","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of peptide nucleic acids (PNAs) with antibacterial activities: Efficacy, potential and challenges","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107083"}}